Not Signed In -
Male Genital Disorders |
Penile Disorders; Testicular Disorders |
Clinical Trial: A study of Cabergoline for the Treatment of Cocaine Dependence - 1
This study is no longer recruiting patients.
Purpose
The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Cabergoline | Phase II |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Official Title: Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence
Expected Total Enrollment: 140
Study start: June 2001; Study completion: December 2003
To assess the efficacy and safety of cabergoline in reducing cocaine use in subjects with cocaine dependence. This is a DB, placebo-controlled, parallel group design study where subjects will receive either .5mg cabergoline or placebo for 12 weeks with a 4 week follow-up.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Must have a DSM-4 criteria for cocaine dependence; be seeking treatment for cocaine dependence; have the ability to understand and provide written informed consent; females of child-bearing potential using proper method of birth control.
Exclusion Criteria:
Additional criteria available during screening at the site.
Location Information
California
Torrance Clinic, Torrance, California, 90502, United States
South Carolina
Medical University of South Carolina, Charleston, South Carolina, 29425, United States
Steve Shoptaw, Ph.D., Principal Investigator, Friends Research Institute
More Information
Record last reviewed: March 2004
Last Updated: November 18, 2004
Record first received: April 5, 2002
ClinicalTrials.gov Identifier: NCT00033111
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Ambiguous Genitalia (Mayo Foundation for Medical Education and Research)
- American Foundation for Urologic Disease
email this page
print this page
bookmark this page
feedback on this page
